Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Stiff

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2018
A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile-associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell TransplantationKathleen M Mullane, Drew J Winston, Ajay Nooka, et al.
Lancet (London, England)|March 23, 2015
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trialCraig H Moskowitz, Auayporn Nademanee, Tamas Masszi, et al.
The New England Journal of Medicine|January 25, 2002
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent feverThomas J Walsh, Peter Pappas, Drew J Winston, et al.
Blood|February 7, 2013
Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trialJennifer A Kanakry, Hailun Li, Lan L Gellert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2010
Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern eraAndrew M Evens, Kevin A David, Irene Helenowski, et al.
The Journal of Clinical Investigation|June 10, 2014
Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftmentMitchell E Horwitz, Nelson J Chao, David A Rizzieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic CancerDaniel V T Catenacci, Melissa R Junttila, Theodore Karrison, et al.
Transplantation and Cellular Therapy|July 25, 2022
Health-Related Quality of Life in Young Adult Survivors of Hematopoietic Cell TransplantationSeth J Rotz, Jean C Yi, Betty K Hamilton, et al.
Haematologica|December 6, 2018
Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivorsNavneet S Majhail, Elizabeth Murphy, Purushottam Laud, et al.
Transplantation and Cellular Therapy|March 4, 2023
Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple MyelomaRajshekhar Chakraborty, Jean Yi, Lisa Rybicki, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2018
A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile-associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell TransplantationKathleen M Mullane, Drew J Winston, Ajay Nooka, et al.
Lancet (London, England)|March 23, 2015
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trialCraig H Moskowitz, Auayporn Nademanee, Tamas Masszi, et al.
The New England Journal of Medicine|January 25, 2002
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent feverThomas J Walsh, Peter Pappas, Drew J Winston, et al.
Blood|February 7, 2013
Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trialJennifer A Kanakry, Hailun Li, Lan L Gellert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2010
Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern eraAndrew M Evens, Kevin A David, Irene Helenowski, et al.
The Journal of Clinical Investigation|June 10, 2014
Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftmentMitchell E Horwitz, Nelson J Chao, David A Rizzieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic CancerDaniel V T Catenacci, Melissa R Junttila, Theodore Karrison, et al.
Transplantation and Cellular Therapy|July 25, 2022
Health-Related Quality of Life in Young Adult Survivors of Hematopoietic Cell TransplantationSeth J Rotz, Jean C Yi, Betty K Hamilton, et al.
Haematologica|December 6, 2018
Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivorsNavneet S Majhail, Elizabeth Murphy, Purushottam Laud, et al.
Transplantation and Cellular Therapy|March 4, 2023
Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple MyelomaRajshekhar Chakraborty, Jean Yi, Lisa Rybicki, et al.
Pageof 6